Nosodes
The European HMPWG
should review and reformulate
the official requirements for
Nosodes in a positive way!
Nosodes
WHC Prague 2021

World Health Congress 2021 Prague
10th – 12th September

WHC Prague 2021
Microbiological- and Phytotherapy
AMR
Microbiological Therapy and Phytotherapy
Best complementary medicine options
to reduce antibiotic treatment
Layer für Überschrift
Complementary and Alternative Medicine

ANME advocates for Complementary
and Alternative Medicine in Europe

Layer für Überschrift
previous arrow
next arrow
Shadow

Partner

who

 

Logo UNESCO Kommission Deutschland

 

epha 2016

 

ECAMP

 

SALUS Network

 

European Parliament, Brussels, Belgium 9.1.2018 – Report by Lauren Tuchman, ANME e.V.

This event at the European Parliament involved the European Medicines Agency (EMA) and was co-hosted by WEMOS (an independent civil society organization based in the Netherlands, whose aim is to improve public health worldwide)...

One intent behind this event was to discuss and understand how the European Medicines Agency (EMA) tackles the idea of transparency, and how the EMA is addressing and minimizing ‘conflicts of interest’. An additional focus was on a discussion of EMA’s openness/willingness to work toward greater attention, time, and allocation of resources to the idea of ‘added therapeutic value.’ This added therapeutic value could be applied to new medicines and independent clinical research as a precursor to decisions made on marketing authorization and acceptance of new pharmaceuticals; added therapeutic value could also aid in assessing, monitoring, enforcing safety, standardization, and accountability for those pharmaceuticals that are already approved and on the market.

Read on PDFanhang

Universal Access & Affordable Medicines Forum of the European Public Health Alliance, organized by the European Public Health Alliance (epha) under the auspices of the Belgian Ministry of Health 21.11. 2017

By Lauren Tuchman, ANME

This was a well-attended event filled with varying participants from a multitude of organizations. The atmosphere was lively, questions were raised, and the panels throughout the days were diverse, interactive, and the members actively engaged with the attendees. In the opening remarks from Yannis Nastis, (Policy Manager, Universal Access and Affordable Medicines, European Public Health Alliance [EPHA]), one point was made that was reiterated by many of the panelists of the day: Access to medicine is no longer just a topic and concern for the Ministry of Health; it is important that the Ministry of Finance become more involved and address public concerns.